Skip to content

Randomized Trial between LigaSure Small Jaw Versus Conventional Vessel Ligation in Thyroidectomy

Randomized Trial between LigaSure Small Jaw Versus Conventional Vessel Ligation in Thyroidectomy - Plan Randomized Trial between LigaSure Small Jaw Versus Conventional Vessel Ligation in Thyroidectomy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007137
Enrollment
100
Registered
2012-01-25
Start date
2012-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

LigaSure Small Jaw group conventional ligation group

Sponsors

Kuma Hospital, Shinkokai Medical Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients aged 20 years or older 2) Patients scheduled to undergo total thyroidectomy with unilateral dissection for thyroid cancer 3) Patients with no history of similar surgery 4) Patients with preserved major organ function 5) Patients providing written informed consent for participation in the study

Exclusion criteria

Exclusion criteria: 1) Patients requiring concurrent resection of the trachea, etc. due to adjacent organ involvement 2) Patients with active bacterial and/or fungal infections 3) Patients receiving continued systemic (oral or intravenous) steroids 4) Patients with uncontrolled diabetes mellitus (HbA1c >8.0%) 5) Patients with psychiatric disorder or psychiatric symptoms that would preclude the participation in the study 6) Any others judged by the doctor in charge to be ineligible for subjects in the study

Design outcomes

Secondary

MeasureTime frame
amount of blood loss, amount of drainage, lymphatic leakage, length of hospital stay, duration of drainage, comparison of medical costs (labor costs, number of sutures used, operating time, etc.), fatigue levels of the operator, incidence of intraoperative adverse events, incidence of postoperative adverse events

Primary

MeasureTime frame
Operating time

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026